Cargando…
Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608406/ https://www.ncbi.nlm.nih.gov/pubmed/26648407 http://dx.doi.org/10.1038/leu.2015.312 |
| _version_ | 1783604832321404928 |
|---|---|
| author | List, A F Bennett, J M Sekeres, M A Skikne, B Fu, T Shammo, J M Nimer, S D Knight, R D Giagounidis, A |
| author_facet | List, A F Bennett, J M Sekeres, M A Skikne, B Fu, T Shammo, J M Nimer, S D Knight, R D Giagounidis, A |
| author_sort | List, A F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7608406 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76084062020-11-05 Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS List, A F Bennett, J M Sekeres, M A Skikne, B Fu, T Shammo, J M Nimer, S D Knight, R D Giagounidis, A Leukemia Erratum Nature Publishing Group UK 2015-12-09 2015 /pmc/articles/PMC7608406/ /pubmed/26648407 http://dx.doi.org/10.1038/leu.2015.312 Text en © Macmillan Publishers Limited 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Erratum List, A F Bennett, J M Sekeres, M A Skikne, B Fu, T Shammo, J M Nimer, S D Knight, R D Giagounidis, A Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS |
| title | Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS |
| title_full | Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS |
| title_fullStr | Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS |
| title_full_unstemmed | Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS |
| title_short | Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS |
| title_sort | erratum: extended survival and reduced risk of aml progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) mds |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608406/ https://www.ncbi.nlm.nih.gov/pubmed/26648407 http://dx.doi.org/10.1038/leu.2015.312 |
| work_keys_str_mv | AT listaf erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT bennettjm erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT sekeresma erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT skikneb erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT fut erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT shammojm erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT nimersd erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT knightrd erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT giagounidisa erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds AT erratumextendedsurvivalandreducedriskofamlprogressioninerythroidresponsivelenalidomidetreatedpatientswithlowerriskdel5qmds |